AstraZeneca Aktie
147,60
EUR
-0,75
EUR
-0,51
%
146,75
EUR
-1,20
EUR
-0,81
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
AstraZeneca Aktie Analyse
| 08.10.18 | AstraZeneca buy | Deutsche Bank AG | |
| 26.09.18 | AstraZeneca buy | Deutsche Bank AG | |
| 25.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.09.18 | AstraZeneca Neutral | UBS AG | |
| 24.09.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.09.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 11.09.18 | AstraZeneca Outperform | BNP PARIBAS | |
|
Werbung
|
|||
| 07.09.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.09.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 31.08.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.08.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 16.08.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.08.18 | AstraZeneca Reduce | HSBC | |
| 10.08.18 | AstraZeneca overweight | Barclays Capital | |
| 07.08.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.08.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.08.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 30.07.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.07.18 | AstraZeneca Neutral | UBS AG | |
| 30.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 27.07.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 27.07.18 | AstraZeneca Hold | S&P Capital IQ | |
| 27.07.18 | AstraZeneca overweight | Barclays Capital | |
| 27.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 26.07.18 | AstraZeneca Neutral | UBS AG | |
| 26.07.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.07.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.07.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 13.07.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 09.07.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 02.07.18 | AstraZeneca Neutral | UBS AG | |
| 27.06.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 25.06.18 | AstraZeneca Neutral | UBS AG | |
| 15.06.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 13.06.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.06.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 06.06.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.06.18 | AstraZeneca buy | Deutsche Bank AG | |
| 30.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.05.18 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.05.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 23.05.18 | AstraZeneca Hold | S&P Capital IQ | |
| 22.05.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 22.05.18 | AstraZeneca overweight | Barclays Capital | |
| 22.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 22.05.18 | AstraZeneca buy | Deutsche Bank AG | |
Werbung
Werbung